BLUEPRINT MEDICINES CORP (BPMC)

US09627Y1091 - Common Stock

86.09  +0.91 (+1.07%)

After market: 86.09 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
180.1M
-77.31%		204M
13.27%		249.38M
22.25%		400.57M
60.63%
EBITDA
YoY % growth
-635.5M
-301.55%		-525.8M
17.26%		-474.612M
9.74%		-349.556M
26.35%
EBIT
YoY % growth
-642M
-307.97%		-537.5M
16.28%		-486.277M
9.53%		-340.495M
29.98%
Operating Margin
-356.47%-263.48%-194.99%-85.00%
EPS
YoY % growth
-10.92
-308.40%		-9.35
14.38%		-8.36
10.59%		-5.66
32.29%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-1.70
21.00%
Revenue
Q2Q % growth		81.943M
29.45%
EBITDA
Q2Q % growth		-96.9M
EBIT
Q2Q % growth		-97.563M
21.45%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -1.82
31.32%		-2.080.2612.53%
Q3 2023
Q2Q % growth		 -2.20
1.35%		-2.410.218.88%
Q2 2023
Q2Q % growth		 -2.19
18.28%		-2.590.4015.46%
Q1 2023
Q2Q % growth		 -2.15
-20.11%		-2.720.5721.05%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 71.957M
85.46%		67.61M4.347M6.43%
Q3 2023
Q2Q % growth		 56.6M
-14.24%		51.407M5.193M10.10%
Q2 2023
Q2Q % growth		 57.6M
57.81%		46.375M11.225M24.20%
Q1 2023
Q2Q % growth		 63.3M
0.96%		42.795M20.505M47.91%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.04% 4.43% 0.06% 0.71%
Revenue0% 5.29% 0% 0.79%